Navidea Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Navidea Biopharma (NAVB) Misses Q2 EPS by 1c
August 4, 2016 7:00 AM EDTNavidea Biopharma (NYSE: NAVB) reported Q2 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $5.24 million.
For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.
... More